Renal Denervation Market Report: Trends, Forecast and Competitive Analysis

Renal Denervation Market Trends and Forecast

The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets. The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028. The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.

Renal Denervation Market by Technology, Product, Disease, and End Use Industry

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched and other details of the global renal denervation market report, please download the report brochure.

Renal Denervation Market by Segments

Renal Denervation Market by Segment

The study includes a forecast for the global renal denervation market by technology, product type, disease type, end use industry, and region, as follows:

Renal Denervation Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:

Micro infusion

Pharmacologic ablation

Radiofrequency ablation

Ultrasound ablation

Renal Denervation Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:

EnligHTN RD system

Symplicity RD system

Vessix RD system

Paradise RD system

Iberis RD system

Others

Renal Denervation Market by Disease Type [Value ($B) Shipment Analysis from 2017 to 2028]:

Hypertension

Heart failure

Diabetes

Renal failure

Others

Renal Denervation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

Renal Denervation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of Renal Denervation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies renal denervation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the renal denervation companies profiled in this report include.

Medtronic

Boston Scientific

Kona Medical; Abbott

CardioSonic

Renal Dynamics

Ablative Solutions

Renal Denervation Market Insights

Lucintel forecasts that enligHTN will remain the largest segment over the forecast period due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension.

Ultrasound ablation is expected to remain the largest segment due to its efficacy in trials and high effectiveness of catheter-based renal denervation procedures.

North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities in the region.

Features of the Renal Denervation Market

Market Size Estimates: Renal Denervation market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: Renal Denervation market size by various segments, such as by technology, product type, disease type, end use industry, and region

Regional Analysis: Renal Denervation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different by technology, product type, disease type, end use industry, and regions for the renal denervation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the renal denervation market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the renal denervation market size?

Answer: The global renal denervation market is expected to reach an estimated $xx billion by 2028.

Q2. What is the growth forecast for renal denervation market?

Answer: The global renal denervation market is expected to grow with a CAGR of 36% to 38% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the renal denervation market?

Answer: The major drivers for this market are rising frequency of hypertension, increasing elderly population and clinical advantages.

Q4. What are the major segments for renal denervation market?

Answer: The future of the renal denervation market looks promising with opportunities in the hospitals, clinics, ambulatory surgical centers and other markets

Q5. Who are the key renal denervation companies?

Answer: Some of the key renal denervation companies are as follows:

Medtronic

Boston Scientific

Kona Medical; Abbott

CardioSonic

Renal Dynamics

Ablative Solutions

Q6. Which renal denervation segment will be the largest in future?

Answer: Lucintel forecasts that enligHTN will remain the largest segment over the forecast period due to the rising implementation of clinical studies to examine its efficacy in treating drug-resistant, uncontrolled hypertension.

Q7. In renal denervation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to the increasing diagnosis and treatment rates, high adoption of advanced devices and growing number of research and development activities.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the renal denervation market by technology (micro infusion, pharmacologic ablation, radiofrequency ablation, and ultrasound ablation), product type (enligHTN RD system, symplicity RD system, vessix RD system, paradise RD system, iberis RD system and others), disease type (hypertension, heart failure, diabetes, renal failure and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to renal denervation market or related to renal denervation companies, renal denervation market size, renal denervation market share, renal denervation analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Please note: it takes 2 weeks’ time for reports to be delivered after receiving the order confirmation.